加强以患者为中心的护理:一项随机研究,研究化学疗法诱导的中性质的G-CSF给药偏好
Nathaniel Scher1,2, Hanène Boudabous3,4, Judith Partouche5,6
1Rafael Institute, Integrative Medicine Center, Levallois-Perret, France. n.scher@rt-hartmann.fr.
概括
癌症患者更喜欢佩格菲尔格拉斯蒂姆笔设备而不是注射器,以预防化疗诱导的中性质减退. 笔提供了更低的疼痛和更好的情绪反应,增强患者的自主性和护理.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 患者护理 患者护理
背景情况:
- 化疗诱导的中性质减退是癌症患者的重大风险.
- 佩格菲尔格拉斯蒂姆通常用于预防中性衰竭.
- 患者对不同佩格菲尔格拉斯蒂姆输送器件的偏好尚未得到充分了解.
研究的目的:
- 为了比较Pegfilgrastim预填注射器和笔器件之间的患者偏好和经验.
- 评估诸如疼痛,情绪反应,自主和对护理的满意度等因素.
主要方法:
- 进行了一项前性的,开放的,随机的,观察性试验 (NCT05910164).
- 150名接受化疗的患者被随机分配,首先接受注射器或笔,并进行交叉治疗.
- 患者问卷评估了他们的偏好,学习,自主,疼痛,情绪,满意度和赋权.
主要成果:
- 两组人都更喜欢使用笔器,而不是注射器 (p=0.00106).
- 患者报告说,随着笔的使用,疼痛明显减少,积极情绪更强烈.
- 在注射器的使用中,人们对护理的满意度更高;在自主使用笔时,增强了权力.
结论:
- 患者表示更喜欢佩格菲尔格拉斯蒂姆笔器件.
- 设备偏好可能会受到服用顺序和自我管理经验的影响.
- 这些发现可以为管理中性质衰竭的以患者为中心的护理策略提供信息.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
149
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
149
Nursing Ethical Principles II
924
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
924
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
175
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
175
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K


